0001728411-19-000001.txt : 20190315 0001728411-19-000001.hdr.sgml : 20190315 20190315142944 ACCESSION NUMBER: 0001728411-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190315 DATE AS OF CHANGE: 20190315 EFFECTIVENESS DATE: 20190315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DMC Biotechnologies, Inc. CENTRAL INDEX KEY: 0001728411 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-303493 FILM NUMBER: 19684638 BUSINESS ADDRESS: STREET 1: 5333 EUCLID AVENUE CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: (303) 210-2829 MAIL ADDRESS: STREET 1: 5333 EUCLID AVENUE CITY: BOULDER STATE: CO ZIP: 80303 D/A 1 primary_doc.xml X0708 D/A LIVE 0001728411 DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 BOULDER CO COLORADO 80301 (720) 239-7239 DELAWARE None None Corporation true 2017 Matthew L. Lipscomb c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Executive Officer Director Michael D. Lynch c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Rob van der Meij c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Carolyn Fritz c/o DMC Biotechnologies, Inc. 2477 55th Street, Suite 120 Boulder CO COLORADO 80301 Director Biotechnology Decline to Disclose 06b true 0001728411-18-000001 2018-01-04 true true true true false 0 2537660 2537660 0 Offer and Sale of Series Seed Preferred Stock and Series Seed Preferred Stock Warrants (and the shares issuable thereunder) false 3 0 0 0 false DMC Biotechnologies, Inc. Matthew L. Lipscomb Matthew L. Lipscomb Chief Executive Officer 2019-03-15